Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Champions Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.014 Good day, everyone, and welcome to the Champions Oncology fourth quarter fiscal year 00:00:04.014 -- 00:00:09.098 2026 earnings call. At this time, all participants are placed on a 00:00:09.098 -- 00:00:13.462 listen-only mode. If you have any questions or comments during the presentation, you 00:00:13.462 -- 00:00:18.506 may press star 1 to enter the question queue at any time, and we will open the floor 00:00:18.506 -- 00:00:22.269 for your questions and comments after the presentation. 00:00:22.269 -- 00:00:27.712 It is now my pleasure to hand the floor over to your host, Rob Brainin, CEO, 00:00:31.422 -- 00:00:33.662 Thank you. 00:00:34.683 -- 00:00:39.665 Good afternoon, and thank you for joining our fiscal 2026 year-end earnings call. 00:00:39.665 -- 00:00:45.168 I'm Ron Brainin, CEO of Champions Oncology, and I'm joined today by our CFO, David Miller. 00:00:45.168 -- 00:00:49.310 Before we begin, I'll remind everyone that today's remarks may include forward-looking 00:00:49.310 -- 00:00:54.132 statements. Actual results may differ materially, and you can find more information in 00:00:54.132 -- 00:00:56.633 our filings with the SEC. 00:00:56.633 -- 00:01:01.694 I'd like to begin by referring back to what I said shortly after second 00:01:02.966 -- 00:01:07.108 I said then that we will build on the progress the company has made over the recent years, 00:01:07.108 -- 00:01:11.691 stay focused on positive adjusted EBITDA for the year, and at the same time keep investing 00:01:11.691 -- 00:01:16.373 in our two growth vectors, data and Corellia, with returns on those investments coming 00:01:16.373 -- 00:01:21.636 in later quarters and years, as well as continuing to invest in our TOS business, especially 00:01:21.636 -- 00:01:24...